Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45–55 of the Duchenne muscular dystrophy (DMD) gene

被引:0
|
作者
Daigo Miyazaki
Kunihiro Yoshida
Kazuhiro Fukushima
Akinori Nakamura
Kayo Suzuki
Toshiyuki Sato
Shin'ichi Takeda
Shu-ichi Ikeda
机构
[1] Shinshu University School of Medicine,Department of Medicine (Neurology and Rheumatology)
[2] National Institute of Neuroscience,Department of Molecular Therapy
[3] National Center of Neurology and Psychiatry,Department of Instrumental Analysis
[4] Research Center for Human and Environmental Science,Science Solutions Division
[5] Shinshu University,undefined
[6] Mizuho Information and Research Institute,undefined
来源
Journal of Human Genetics | 2009年 / 54卷
关键词
breakpoint; deletion; Duchenne muscular dystrophy (DMD); dystrophin; genomic sequence; X-linked dilated cardiomyopathy (XLDCM);
D O I
暂无
中图分类号
学科分类号
摘要
Deletion of exons 45–55 (del45–55) in the Duchenne muscular dystrophy gene (DMD) has gained particular interest in the field of molecular therapy, because it causes a milder phenotype than DMD, and therefore, may represent a good candidate for the goal of a multiple exon-skipping strategy. We have precisely characterized deletion breakpoints in three patients with del45–55 in DMD. Two of them were young adult males of the X-linked dilated cardiomyopathy phenotype, and the third patient revealed the mild Becker muscular dystrophy phenotype of late onset. The deletion breakpoints differed among patients. The deletion started at nt 226 604, 231 518, 117 284 in intron 44, and ended at nt 64 994, 59 314, 71 806 in intron 55, respectively. Deletion junctions showed no significant homology between the sequences adjacent to the distal and proximal end joints in these patients. Deletion breakpoints were not primarily associated with any particular sequence element, or with a matrix attachment region. However, there were several palindromic sequences and short tandem repeats at or near the breakpoints. These sequences, with a marked propensity to form secondary DNA structure intermediates, may predispose local DNA to breakage and intragenic recombination in these patients.
引用
收藏
页码:127 / 130
页数:3
相关论文
共 50 条
  • [1] Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene
    Miyazaki, Daigo
    Yoshida, Kunihiro
    Fukushima, Kazuhiro
    Nakamura, Akinori
    Suzuki, Kayo
    Sato, Toshiyuki
    Takeda, Shin'ichi
    Ikeda, Shu-ichi
    JOURNAL OF HUMAN GENETICS, 2009, 54 (02) : 127 - 130
  • [2] Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene
    Nakamura, Akinorl
    Yoshida, Kunihiro
    Fukushima, Kazuhiro
    Ueda, Hideho
    Urasawa, Nobuyuki
    Koyama, Jun
    Yazaki, Yoshikazu
    Yazaki, Masahide
    Sakai, Toshiaki
    Haruta, Seiichi
    Takeda, Shin'ichi
    Ikeda, Shu-ichi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (07) : 757 - 763
  • [3] Dystrophinopathic subjects with a specific mega-deletion of exons 45-55 in the DMD gene, as a template for CRISPR/Cas9 therapy in Duchenne muscular dystrophy
    Poyatos-Garcia, J.
    Soblechero-Martin, P.
    Albiasu-Arteta, E.
    Arechavala-Gomeza, V.
    Vazquez-Manrique, R.
    Muelas, N.
    Marti, P.
    Gomis, C.
    Vilchez, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S151 - S152
  • [4] Implication of the breakpoints position in patients with the macrodeletion of exons 45 to 55 in the DMD gene
    Poyatos-Garcia, J.
    Muelas Gomez, N.
    Gomis, C.
    Marti, P.
    Pitarch, I.
    Vilchez, J. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 693 - 693
  • [5] New deletion constructs of dystrophin for gene therapy of duchenne muscular dystrophy (DMD)
    Lochmuller, H
    Orlopp, K
    Dunant, P
    Larochelle, N
    Stucka, R
    NEUROLOGY, 2000, 54 (07) : A271 - A272
  • [6] Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model
    Poyatos-Garcia, Javier
    Soblechero-Martin, Patricia
    Liquori, Alessandro
    Lopez-Martinez, Andrea
    Maestre, Pilar
    Gonzalez-Romero, Elisa
    Vazquez-Manrique, Rafael P.
    Muelas, Nuria
    Garcia-Garcia, Gema
    Ohana, Jessica
    Arechavala-Gomeza, Virginia
    Vilchez, Juan J.
    SKELETAL MUSCLE, 2024, 14 (01):
  • [7] Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45-55 Deletion
    Poyatos-Garcia, Javier
    Marti, Pilar
    Liquori, Alessandro
    Muelas, Nuria
    Pitarch, Inmaculada
    Martinez-Dolz, Luis
    Rodriguez, Benjamin
    Gonzalez-Quereda, Lidia
    Damia, Maria
    Aller, Elena
    Selva-Gimenez, Marta
    Vilchez, Roger
    Diaz-Manera, Jordi
    Alonso-Perez, Jorge
    Eulalio Barcena, Jose
    Jauregui, Amaia
    Gamez, Josep
    Angel Aladren, Jesus
    Fernandez, Ariadna
    Montolio, Marisol
    Azorin, Inmaculada
    Hervas, David
    Casasus, Ana
    Nieto, Marisa
    Gallano, Pia
    Sevilla, Teresa
    Jesus Vilchez, Juan
    ANNALS OF NEUROLOGY, 2022, 92 (05) : 793 - 806
  • [8] DUCHENNE MUSCULAR-DYSTROPHY (DMD) - SEVERITY OF ROD DYSFUNCTION CORRELATES WITH LOCATION OF DELETION IN DMD GENE
    SIGESMUND, DA
    RAY, PN
    PILLERS, DM
    WELEBER, RG
    WESTALL, CA
    PANTON, CM
    MUSARELLA, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 1463 - 1463
  • [9] AN ISOLATED CASE OF DUCHENNE MUSCULAR-DYSTROPHY (DMD) IN A FEMALE WITH A DELETION OF DMD CDNA
    YOSHIOKA, M
    YAMAMOTO, Y
    FURUYAMA, JI
    CLINICAL GENETICS, 1990, 38 (06) : 474 - 478
  • [10] A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20
    Lopez, Sara Mata
    Hammond, James J.
    Rigsby, Madison B.
    Balog-Alvarez, Cynthia J.
    Kornegay, Joe N.
    Nghiem, Peter P.
    SKELETAL MUSCLE, 2018, 8